Essential role of mu opioid receptor in the regulation of delta opioid receptor-mediated antihyperalgesia

Neuroscience

Volumn 150, Issue 4, 2007, Pages 807-817

  Gendron, L ^a   Pintar, J E ^b   Chavkin, C ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

antihyperalgesia; delta opioid receptor (DOR); deltorphin II; inflammation; mu opioid receptor (MOR)

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; BETA ENDORPHIN; DELTA OPIATE RECEPTOR; DELTORPHIN; DELTORPHIN II; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; DYNORPHIN; ENKEPHALIN; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NALTRINDOLE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; HYPERALGESIA; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; RECEPTOR INTRINSIC ACTIVITY;

ANIMALS; BETA-ENDORPHIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DYNORPHINS; ENKEPHALINS; FREUND'S ADJUVANT; HYPERALGESIA; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; NALTREXONE; NARCOTIC ANTAGONISTS; OLIGOPEPTIDES; PAIN MEASUREMENT; PROTEIN PRECURSORS; REACTION TIME; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; SOMATOSTATIN;

EID: 36849030317     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.09.060     Document Type: Article

References (84)

1. Arvidsson U., Riedl M., Chakrabarti S., Lee J.H., Nakano A.H., Dado R.J., Loh H.H., Law P.Y., Wessendorf M.W., and Elde R. Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J Neurosci 15 (1995) 3328-3341
2. Bodnar R.J., and Klein G.E. Endogenous opiates and behavior: 2004. Peptides 26 (2005) 2629-2711
3. Brandt M.R., Furness M.S., Mello N.K., Rice K.C., and Negus S.S. Antinociceptive effects of delta-opioid agonists in rhesus monkeys: effects on chemically induced thermal hypersensitivity. J Pharmacol Exp Ther 296 (2001) 939-946
4. Brandt M.R., Furness M.S., Rice K.C., Fischer B.D., and Negus S.S. Studies of tolerance and dependence with the delta-opioid agonist SNC80 in rhesus monkeys responding under a schedule of food presentation. J Pharmacol Exp Ther 299 (2001) 629-637
5. Broom D.C., Jutkiewicz E.M., Folk J.E., Traynor J.R., Rice K.C., and Woods J.H. Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats. Neuropsychopharmacology 26 (2002) 744-755
6. Cabot P.J., Carter L., Gaiddon C., Zhang Q., Schafer M., Loeffler J.P., and Stein C. Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats. J Clin Invest 100 (1997) 142-148
7. Cahill C.M., Holdridge S.V., and Morinville A. Trafficking of delta-opioid receptors and other G-protein-coupled receptors: implications for pain and analgesia. Trends Pharmacol Sci 28 (2007) 23-31
8. Cahill C.M., McClellan K.A., Morinville A., Hoffert C., Hubatsch D., O'Donnell D., and Beaudet A. Immunohistochemical distribution of delta opioid receptors in the rat central nervous system: evidence for somatodendritic labeling and antigen-specific cellular compartmentalization. J Comp Neurol 440 (2001) 65-84
9. Cahill C.M., Morinville A., Lee M.C., Vincent J.P., Collier B., and Beaudet A. Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception. J Neurosci 21 (2001) 7598-7607
10. Cahill C.M., Morinville A., Hoffert C., O'Donnell D., and Beaudet A. Up-regulation and trafficking of delta opioid receptor in a model of chronic inflammation: implications for pain control. Pain 101 (2003) 199-208
11. Cheng P.Y., Liu-Chen L.Y., and Pickel V.M. Dual ultrastructural immunocytochemical labeling of mu and delta opioid receptors in the superficial layers of the rat cervical spinal cord. Brain Res 778 (1997) 367-380
12. Cheng P.Y., Svingos A.L., Wang H., Clarke C.L., Jenab S., Beczkowska I.W., Inturrisi C.E., and Pickel V.M. Ultrastructural immunolabeling shows prominent presynaptic vesicular localization of delta-opioid receptor within both enkephalin- and nonenkephalin-containing axon terminals in the superficial layers of the rat cervical spinal cord. J Neurosci 15 (1995) 5976-5988
13. Colpaert F.C. System theory of pain and of opiate analgesia: no tolerance to opiates. Pharmacol Rev 48 (1996) 355-402
14. Cowan A., Zhu X.Z., Mosberg H.I., Omnaas J.R., and Porreca F. Direct dependence studies in rats with agents selective for different types of opioid receptor. J Pharmacol Exp Ther 246 (1988) 950-955
15. Desmeules J.A., Kayser V., Gacel G., Guilbaud G., and Roques B.P. The highly selective delta agonist BUBU induces an analgesic effect in normal and arthritic rat and this action is not affected by repeated administration of low doses of morphine. Brain Res 611 (1993) 243-248
16. Egan T.M., and North R.A. Both mu and delta opiate receptors exist on the same neuron. Science 214 (1981) 923-924
17. Elde R., Arvidsson U., Riedl M., Vulchanova L., Lee J.H., Dado R., Nakano A., Chakrabarti S., Zhang X., Loh H.H., et al. Distribution of neuropeptide receptors. New views of peptidergic neurotransmission made possible by antibodies to opioid receptors. Ann N Y Acad Sci 757 (1995) 390-404
18. Elliott J., and Traynor J.R. Evidence for lack of modulation of mu-opioid agonist action by delta-opioid agonists in the mouse vas deferens and guinea-pig ileum. Br J Pharmacol 114 (1995) 1064-1068
19. Fairbanks C.A. Spinal delivery of analgesics in experimental models of pain and analgesia. Adv Drug Deliv Rev 55 (2003) 1007-1041
20. Fields H.L., Emson P.C., Leigh B.K., Gilbert R.F., and Iversen L.L. Multiple opiate receptor sites on primary afferent fibres. Nature 284 (1980) 351-353
21. Franklin T.G., and Traynor J.R. Alkylation with beta-funaltrexamine suggests differences between mu-opioid receptor systems in guinea-pig brain and myenteric-plexus. Br J Pharmacol 102 (1991) 718-722
22. Fraser G.L., Gaudreau G.A., Clarke P.B., Menard D.P., and Perkins M.N. Antihyperalgesic effects of delta opioid agonists in a rat model of chronic inflammation. Br J Pharmacol 129 (2000) 1668-1672
23. Fraser G.L., Parenteau H., Tu T.M., Ducharme J., Perkins M.N., and Clarke P.B. The effects of delta agonists on locomotor activity in habituated and non-habituated rats. Life Sci 67 (2000) 913-922
24. Gallantine E.L., and Meert T.F. A comparison of the antinociceptive and adverse effects of the mu-opioid agonist morphine and the delta-opioid agonist SNC80. Basic Clin Pharmacol Toxicol 97 (2005) 39-51
25. Gendron L., Esdaile M.J., Mennicken F., Pan H., O'Donnell D., Vincent J.P., Devi L.A., Cahill C.M., Stroh T., and Beaudet A. Morphine priming in rats with chronic inflammation reveals a dichotomy between antihyperalgesic and antinociceptive properties of deltorphin. Neuroscience 144 (2007) 263-274
26. Gendron L., Lucido A.L., Mennicken F., O'Donnell D., Vincent J.P., Stroh T., and Beaudet A. Morphine and pain-related stimuli enhance cell surface availability of somatic delta-opioid receptors in rat dorsal root ganglia. J Neurosci 26 (2006) 953-962
27. George S.R., Fan T., Xie Z., Tse R., Tam V., Varghese G., and O'Dowd B.F. Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. J Biol Chem 275 (2000) 26128-26135
28. Gomes I., Gupta A., Filipovska J., Szeto H.H., Pintar J.E., and Devi L.A. A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proc Natl Acad Sci U S A 101 (2004) 5135-5139
29. Gomes I., Jordan B.A., Gupta A., Trapaidze N., Nagy V., and Devi L.A. Heterodimerization of mu and delta opioid receptors: A role in opiate synergy. J Neurosci 20 (2000) RC110
30. Guan J.S., Xu Z.Z., Gao H., He S.Q., Ma G.Q., Sun T., Wang L.H., Zhang Z.N., Lena I., Kitchen I., Elde R., Zimmer A., He C., Pei G., Bao L., and Zhang X. Interaction with vesicle luminal protachykinin regulates surface expression of delta-opioid receptors and opioid analgesia. Cell 122 (2005) 619-631
31. Guo X.H., Fairbanks C.A., Stone L.S., and Loh H.H. DPDPE-UK14,304 synergy is retained in mu opioid receptor knockout mice. Pain 104 (2003) 209-217
32. Hack S.P., Bagley E.E., Chieng B.C., and Christie M.J. Induction of delta-opioid receptor function in the midbrain after chronic morphine treatment. J Neurosci 25 (2005) 3192-3198
33. He L., and Lee N.M. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord. J Pharmacol Exp Ther 285 (1998) 1181-1186
34. Hosohata Y., Vanderah T.W., Burkey T.H., Ossipov M.H., Kovelowski C.J., Sora I., Uhl G.R., Zhang X., Rice K.C., Roeske W.R., Hruby V.J., Yamamura H.I., Lai J., and Porreca F. delta-Opioid receptor agonists produce antinociception and [35S]GTPgammaS binding in mu receptor knockout mice. Eur J Pharmacol 388 (2000) 241-248
35. Hough L.B., Nalwalk J.W., Chen Y., Schuller A., Zhu Y., Zhang J., Menge W.M., Leurs R., Timmerman H., and Pintar J.E. Improgan, a cimetidine analog, induces morphine-like antinociception in opioid receptor-knockout mice. Brain Res 880 (2000) 102-108
36. Hurley R.W., and Hammond D.L. The analgesic effects of supraspinal mu and delta opioid receptor agonists are potentiated during persistent inflammation. J Neurosci 20 (2000) 1249-1259
37. Hurley R.W., and Hammond D.L. Contribution of endogenous enkephalins to the enhanced analgesic effects of supraspinal mu opioid receptor agonists after inflammatory injury. J Neurosci 21 (2001) 2536-2545
38. Hylden J.L., Thomas D.A., Iadarola M.J., Nahin R.L., and Dubner R. Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: possible involvement of noradrenergic mechanisms. Eur J Pharmacol 194 (1991) 135-143
39. Iadarola M.J., Douglass J., Civelli O., and Naranjo J.R. Differential activation of spinal cord dynorphin and enkephalin neurons during hyperalgesia: evidence using cDNA hybridization. Brain Res 455 (1988) 205-212
40. Jordan B.A., and Devi L.A. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399 (1999) 697-700
41. Jutkiewicz E.M., Eller E.B., Folk J.E., Rice K.C., Traynor J.R., and Woods J.H. Delta-opioid agonists: differential efficacy and potency of SNC80, its 3-OH (SNC86) and 3-desoxy (SNC162) derivatives in Sprague-Dawley rats. J Pharmacol Exp Ther 309 (2004) 173-181
42. Khotib J., Narita M., Suzuki M., Yajima Y., and Suzuki T. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors. Neuropharmacology 46 (2004) 531-540
43. Konig M., Zimmer A.M., Steiner H., Holmes P.V., Crawley J.N., Brownstein M.J., and Zimmer A. Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature 383 (1996) 535-538
44. Kreek M.J. Opioid receptors: some perspectives from early studies of their role in normal physiology, stress responsivity, and in specific addictive diseases. Neurochem Res 21 (1996) 1469-1488
45. Law P.Y., Erickson-Herbrandson L.J., Zha Q.Q., Solberg J., Chu J., Sarre A., and Loh H.H. Heterodimerization of mu- and delta-opioid receptors occurs at the cell surface only and requires receptor-G protein interactions. J Biol Chem 280 (2005) 11152-11164
46. Loh H.H., Liu H.C., Cavalli A., Yang W., Chen Y.F., and Wei L.N. mu Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality. Brain Res Mol Brain Res 54 (1998) 321-326
47. Longoni R., Spina L., Mulas A., Carboni E., Garau L., Melchiorri P., and Di Chiara G. (D-Ala2)deltorphin II: D1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens. J Neurosci 11 (1991) 1565-1576
48. Ma J., Zhang Y., Kalyuzhny A.E., and Pan Z.Z. Emergence of functional {delta}-opioid receptors induced by chronic morphine. Mol Pharmacol 69 (2006) 1137-1145
49. Matthes H.W., Smadja C., Valverde O., Vonesch J.L., Foutz A.S., Boudinot E., Denavit-Saubie M., Severini C., Negri L., Roques B.P., Maldonado R., and Kieffer B.L. Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor. J Neurosci 18 (1998) 7285-7295
50. May C.N., Dashwood M.R., Whitehead C.J., and Mathias C.J. Differential cardiovascular and respiratory responses to central administration of selective opioid agonists in conscious rabbits: correlation with receptor distribution. Br J Pharmacol 98 (1989) 903-913
51. Melchiorri P., Maritati M., Negri L., and Erspamer V. Long-term sensitization to the activation of cerebral delta-opioid receptors by the deltorphin Tyr-D-Ala-Phe-Glu-Val-Val-Gly-NH2 in rats exposed to morphine. Proc Natl Acad Sci U S A 89 (1992) 3696-3700
52. Mennicken F., Zhang J., Hoffert C., Ahmad S., Beaudet A., and O'Donnell D. Phylogenetic changes in the expression of delta opioid receptors in spinal cord and dorsal root ganglia. J Comp Neurol 465 (2003) 349-360
53. Miaskowski C., Sutters K.A., Taiwo Y.O., and Levine J.D. Comparison of the antinociceptive and motor effects of intrathecal opioid agonists in the rat. Brain Res 553 (1991) 105-109
54. Mika J., Przewlocki R., and Przewlocka B. The role of delta-opioid receptor subtypes in neuropathic pain. Eur J Pharmacol 415 (2001) 31-37
55. Millan M.J., Czlonkowski A., Morris B., Stein C., Arendt R., Huber A., Hollt V., and Herz A. Inflammation of the hind limb as a model of unilateral, localized pain: influence on multiple opioid systems in the spinal cord of the rat. Pain 35 (1988) 299-312
56. Millan M.J., Millan M.H., Czlonkowski A., Hollt V., Pilcher C.W., Herz A., and Colpaert F.C. A model of chronic pain in the rat: response of multiple opioid systems to adjuvant-induced arthritis. J Neurosci 6 (1986) 899-906
57. Morinville A., Cahill C.M., Aibak H., Rymar V.V., Pradhan A., Hoffert C., Mennicken F., Stroh T., Sadikot A.F., O'Donnell D., Clarke P.B., Collier B., Henry J.L., Vincent J.P., and Beaudet A. Morphine-induced changes in delta opioid receptor trafficking are linked to somatosensory processing in the rat spinal cord. J Neurosci 24 (2004) 5549-5559
58. Morinville A., Cahill C.M., Kieffer B., Collier B., and Beaudet A. Mu-opioid receptor knockout prevents changes in delta-opioid receptor trafficking induced by chronic inflammatory pain. Pain 109 (2004) 266-273
59. Morinville A., Cahill C.M., Esdaile M.J., Aibak H., Collier B., Kieffer B.L., and Beaudet A. Regulation of delta-opioid receptor trafficking via mu-opioid receptor stimulation: evidence from mu-opioid receptor knock-out mice. J Neurosci 23 (2003) 4888-4898
60. Negri L., Noviello L., and Noviello V. Antinociceptive and behavioral effects of synthetic deltorphin analogs. Eur J Pharmacol 296 (1996) 9-16
61. Negri L., Noviello V., and Angelucci F. Behavioural effects of deltorphins in rats. Eur J Pharmacol 209 (1991) 163-168
62. Noguchi K., Dubner R., and Ruda M.A. Preproenkephalin mRNA in spinal dorsal horn neurons is induced by peripheral inflammation and is co-localized with Fos and Fos-related proteins. Neuroscience 46 (1992) 561-570
63. Parra M.C., Nguyen T.N., Hurley R.W., and Hammond D.L. Persistent inflammatory nociception increases levels of dynorphin 1-17 in the spinal cord, but not in supraspinal nuclei involved in pain modulation. J Pain 3 (2002) 330-336
64. Patwardhan A.M., Berg K.A., Akopain A.N., Jeske N.A., Gamper N., Clarke W.P., and Hargreaves K.M. Bradykinin-induced functional competence and trafficking of the delta-opioid receptor in trigeminal nociceptors. J Neurosci 25 (2005) 8825-8832
65. Patwardhan A.M., Diogenes A., Berg K.A., Fehrenbacher J.C., Clarke W.P., Akopian A.N., and Hargreaves K.M. PAR-2 agonists activate trigeminal nociceptors and induce functional competence in the delta opioid receptor. Pain 125 (2006) 114-124
66. Petrillo P., Angelici O., Bingham S., Ficalora G., Garnier M., Zaratin P.F., Petrone G., Pozzi O., Sbacchi M., Stean T.O., Upton N., Dondio G.M., and Scheideler M.A. Evidence for a selective role of the delta-opioid agonist [8R-(4bS*8aalpha,8abeta, 12bbeta)]7,10-dimethyl-1-methoxy-11-(2-methylpropyl)oxycarbonyl 5,6,7,8,12,12b-hexahydro-(9H)-4,8-methanobenzofuro[3,2-e]pyrrolo[2,3-g]iso quinoline hydrochloride (SB-235863) in blocking hyperalgesia associated with inflammatory and neuropathic pain responses. J Pharmacol Exp Ther 307 (2003) 1079-1089
67. Porreca F., Mosberg H.I., Hurst R., Hruby V.J., and Burks T.F. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. J Pharmacol Exp Ther 230 (1984) 341-348
68. Qiu C., Sora I., Ren K., Uhl G., and Dubner R. Enhanced delta-opioid receptor-mediated antinociception in mu-opioid receptor-deficient mice. Eur J Pharmacol 387 (2000) 163-169
69. Riba P., Ben Y., Smith A.P., Furst S., and Lee N.M. Morphine tolerance in spinal cord is due to interaction between mu- and delta-receptors. J Pharmacol Exp Ther 300 (2002) 265-272
70. Rozenfeld R., and Devi L.A. Receptor heterodimerization leads to a switch in signaling: {beta}-arrestin2-mediated ERK activation by {micro}-{delta} opioid receptor heterodimers. FASEB J 10 (2007) 2455-2465
71. Rubinstein M., Mogil J.S., Japon M., Chan E.C., Allen R.G., and Low M.J. Absence of opioid stress-induced analgesia in mice lacking beta-endorphin by site-directed mutagenesis. Proc Natl Acad Sci U S A 93 (1996) 3995-4000
72. Sanderson Nydahl K., Skinner K., Julius D., and Basbaum A.I. Co-localization of endomorphin-2 and substance P in primary afferent nociceptors and effects of injury: a light and electron microscopic study in the rat. Eur J Neurosci 19 (2004) 1789-1799
73. Scherrer G., Befort K., Contet C., Becker J., Matifas A., and Kieffer B.L. The delta agonists DPDPE and deltorphin II recruit predominantly mu receptors to produce thermal analgesia: a parallel study of mu, delta and combinatorial opioid receptor knockout mice. Eur J Neurosci 19 (2004) 2239-2248
74. Schuller A.G., King M.A., Zhang J., Bolan E., Pan Y.X., Morgan D.J., Chang A., Czick M.E., Unterwald E.M., Pasternak G.W., and Pintar J.E. Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1. Nat Neurosci 2 (1999) 151-156
75. Sharifi N., Diehl N., Yaswen L., Brennan M.B., and Hochgeschwender U. Generation of dynorphin knockout mice. Brain Res Mol Brain Res 86 (2001) 70-75
76. Sora I., Funada M., and Uhl G.R. The mu-opioid receptor is necessary for [D-Pen2,D-Pen5]enkephalin-induced analgesia. Eur J Pharmacol 324 (1997) R1-R2
77. Sora I., Takahashi N., Funada M., Ujike H., Revay R.S., Donovan D.M., Miner L.L., and Uhl G.R. Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci U S A 94 (1997) 1544-1549
78. Spina L., Longoni R., Mulas A., Chang K.J., and Di Chiara G. Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW373U86 and SNC 80: 1. Locomotion, rearing and stereotypies in intact rats. Behav Pharmacol 9 (1998) 1-8
79. Stewart P.E., and Hammond D.L. Activation of spinal delta-1 or delta-2 opioid receptors reduces carrageenan-induced hyperalgesia in the rat. J Pharmacol Exp Ther 268 (1994) 701-708
80. Szeto H.H., Soong Y., Wu D., Olariu N., Kett A., Kim H., and Clapp J.F. Respiratory depression after intravenous administration of delta-selective opioid peptide analogs. Peptides 20 (1999) 101-105
81. Zadina J.E., Hackler L., Ge L.J., and Kastin A.J. A potent and selective endogenous agonist for the mu-opiate receptor. Nature 386 (1997) 499-502
82. Zhang X., Bao L., Arvidsson U., Elde R., and Hokfelt T. Localization and regulation of the delta-opioid receptor in dorsal root ganglia and spinal cord of the rat and monkey: evidence for association with the membrane of large dense-core vesicles. Neuroscience 82 (1998) 1225-1242
83. Zhang X., Bao L., and Guan J.S. Role of delivery and trafficking of delta-opioid peptide receptors in opioid analgesia and tolerance. Trends Pharmacol Sci 27 (2006) 324-329
84. Zieglgansberger W., French E.D., Mercuri N., Pelayo F., and Williams J.T. Multiple opiate receptors on neurons of the mammalian central nervous system. In vivo and in vitro studies. Life Sci 31 (1982) 2343-2346